Gelteq Limited

Gelteq Limited focuses on developing, testing, and commercializing white label gel-based delivery solutions for humans and animals in Asia-Pacific Region. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. The company has a strategic alliance with IDT Australia Limited for the development and scale up of its gel-based products across diverse global pharmaceutical, nutraceutical and animal health markets and has a strategic alliance with Melbourne Health for the development of maize starch butyrylated, or HAMSB, a compound with the potential to reduce bowel polyp growth which could lower the risk of bowel cancer. Gelteq Limited was incorporated in 2017 and is headquartered in Caulfield, Australia.